BLLN Company Profile and Key Details
NASDAQ : BLLN
BillionToOne
$120.60
2.56+2.17%
At Close 4:00 PMPrice Chart
Stock Price Today
BillionToOne, Inc. (BLLN) stock surged +2.17%, trading at $120.60 on NASDAQ, up from the previous close of $118.04. The stock opened at $117.50, fluctuating between $113.30 and $121.00 in the recent session.
Stock Snapshot
118.04
Prev. Close
5.55B
Market Cap
113.3
Day Low
219.27
P/E Ratio
0.55
EPS (TTM)
N/A
Cash Flow per Share
117.5
Open
46M
Number of Shares
121
Day High
N/A
Free Float in %
N/A
Book Value
629.26K
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 08, 2026 | 117.60 | 121.00 | 113.30 | 120.60 | 630.31K |
| Jul 07, 2026 | 123.54 | 124.00 | 117.12 | 118.04 | 592.53K |
| Jul 06, 2026 | 120.00 | 124.89 | 118.05 | 123.40 | 779.56K |
| Jul 02, 2026 | 123.52 | 123.52 | 118.01 | 120.35 | 611.56K |
| Jul 01, 2026 | 121.26 | 124.99 | 119.50 | 122.33 | 687.67K |
| Jun 30, 2026 | 121.60 | 121.91 | 117.28 | 119.98 | 532K |
| Jun 29, 2026 | 118.74 | 121.31 | 116.15 | 120.40 | 601.31K |
| Jun 26, 2026 | 111.00 | 118.87 | 110.50 | 118.17 | 962.04K |
| Jun 25, 2026 | 108.95 | 114.80 | 108.02 | 112.24 | 837.84K |
| Jun 24, 2026 | 105.80 | 110.85 | 104.47 | 107.74 | 1.16M |
| Jun 23, 2026 | 98.33 | 105.82 | 98.33 | 104.28 | 729.12K |
| Jun 22, 2026 | 104.00 | 104.45 | 98.25 | 100.72 | 807.6K |
| Jun 18, 2026 | 102.01 | 106.55 | 100.01 | 105.15 | 984.68K |
| Jun 17, 2026 | 100.19 | 104.54 | 97.10 | 99.38 | 963.54K |
| Jun 16, 2026 | 104.16 | 105.38 | 99.14 | 100.70 | 724.16K |
| Jun 15, 2026 | 101.47 | 105.00 | 97.65 | 103.95 | 752.03K |
| Jun 12, 2026 | 101.07 | 103.45 | 96.76 | 101.12 | 552.65K |
| Jun 11, 2026 | 100.61 | 103.98 | 98.57 | 99.65 | 667.92K |
| Jun 10, 2026 | 100.15 | 104.89 | 97.87 | 99.26 | 1.04M |
| Jun 09, 2026 | 96.17 | 103.77 | 95.30 | 102.39 | 676.44K |
Contact Details
About Company
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Company Information
| Employees | 620 |
| Beta | 0.47 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
Stock Peers
IDXX
-14.58-2.56%
IDEXX Laboratories, Inc.$555.67MEDP-14.3-2.62%
Medpace Holdings, Inc.$531.99NTRA-6.88-2.45%
Natera, Inc.$274.39ILMN-3.95-2.06%
Illumina, Inc.$187.81ICLR-3.25-1.93%
ICON Public Limited Company$165.47GH-6.75-4.14%
Guardant Health, Inc.$156.17ILMNV1.75+1.66%
Illumina, Inc. Common Stock Ex-distribution When-Issued$107.00EXAS00
Exact Sciences Corporation$104.91TWST-1.65-1.81%
Twist Bioscience Corporation$89.38RDNT-2.24-3.30%
RadNet, Inc.$65.59Company Overview
BillionToOne, Inc. (NASDAQ:BLLN) closed at $120.60 USD, gaining $2.56 (2.17%) from the previous close of $118.04. The stock is currently mid-range between its 52-week high and low $61.96 and $138.70. With a market capitalization of about $5.55 billion, BillionToOne, Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.47). Key stats such as the average daily volume over the past year has been around 699.74 thousand shares, in line with its 52-week average. Headquartered in Menlo Park, CA, BillionToOne, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Oguzhan Atay, the company employs approximately 620 people and listed since November 06, 2025. BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions.
Technical Performance
Short-term trend indicators are bullishly aligned (SMA20 -15.01%, SMA50 -18.7%, SMA200 -24.15%). The stock’s 14-day RSI is 34.74 (weak momentum), while the ATR of 6.83 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -48.51% below its high and over 4.85% above its low. Average 10-day trading volume of 633.56 thousand shares is below the 3-month average of 711.46 thousand, indicating normal recent market interest.
Valuation Metrics
BillionToOne, Inc. trades at a P/E ratio of 232.81, slightly above the S&P 500 average, with a price-to-sales ratio of 15.54 and a price-to-book ratio of 10.88 reflecting a rich premium to book value. The P/FCF stands at 196.19, also above market averages. Compared to sector medians, BillionToOne, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.
Dividend & Fair Value
BillionToOne, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $116.41. This means the shares are trading near this model’s fair value.
Earnings & Analyst Outlook
Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 9 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $160.00 to $100.00. The high target offers 32.67% upside. The low target suggests -17.08% downside. The mean target is $133.25. This offers 10.49% upside. BillionToOne, Inc. earnings surprise history is a mixed track record. The quarter that ended May 06, 2026, missed forecasts by 981.77%. The prior quarter beat by 82.72%. Over the last six quarters, Apple has recorded several small beats. These include -37.5% in December 09, 2025.
Shareholding & Insider Activity
BillionToOne, Inc. has 41.44 million shares outstanding. The public float is 27.55 million shares, elevated short interest at 6.74% of float. This equals 1.68 million shares. The short ratio is 2.22 days.
Price Forecast & Outlook
Our AI price prediction model suggests that BillionToOne, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 12.62%, with price expected at $135.82 by July 22, 2026, within a range of $131.56 to $140.37 3-Month Outlook: Projected rise of 414.65%, reaching $620.67 by October 06, 2026, with a range of $618.30 to $622.55. 1-Year Outlook: Projected loss of -11.27%, with price at $107.01 by July 08, 2027, within a range of $103.33 to $110.83.
Key Takeaways
BillionToOne, Inc. (NASDAQ:BLLN) shares are flat 5.02% year-to-date currently trading near 52-week highs band. Valuation shows BillionToOne, Inc. trading at a premium to the broader market with a P/E of 232.81. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $133.25, suggesting 10.49% upside. Our AI forecast model points to short-term strength (12.62% over two weeks), a medium-term rise (414.65% over three months), and a longer-term loss (-11.27% over one year), with expected trading ranges indicating moderate volatility.
Frequently Asked Questions
What is the current BillionToOne, Inc. (BLLN) stock price?
BillionToOne, Inc. (NASDAQ: BLLN) stock price is $120.60 in the last trading session. During the trading session, BLLN stock reached the peak price of $121.00 while $113.30 was the lowest point it dropped to. The percentage change in BLLN stock occurred in the recent session was 2.17% while the dollar amount for the price change in BLLN stock was $2.56.
BLLN's industry and sector of operation?
The NASDAQ listed BLLN is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. BillionToOne, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of BLLN?
No Data
How BLLN did perform over past 52-week?
BLLN's closing price is 94.64% higher than its 52-week low of $61.96 where as its distance from 52-week high of $138.70 is -13.05%.
How many employees does BLLN have?
Number of BLLN employees currently stands at 620.
Link for BLLN official website?
Official Website of BLLN is: https://www.billiontoone.com
How do I contact BLLN?
BLLN could be contacted at phone 650 460 2551 and can also be accessed through its website. BLLN operates from 1035 OâBrien Drive, Menlo Park, CA 94025, United States.
How many shares of BLLN are traded daily?
BLLN stock volume for the day was 629.26K shares. The average number of BLLN shares traded daily for last 3 months was 699.74K.
What is the market cap of BLLN currently?
The market value of BLLN currently stands at $5.55B with its latest stock price at $120.60 and 46M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep